Mrs. Brittney Grace Hughes, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 6518 Meadowridge Rd, Suite 106, Elkridge, MD 21075 Phone: 443-393-0223 Fax: 443-393-0215 |
Mr. Daniel Metz, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 7472 Cedar Grove Ln, Elkridge, MD 21075 Phone: 443-506-6807 |
Olufemi Otubanjo, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 6480 Old Waterloo Rd, Elkridge, MD 21075 Phone: 410-799-0291 |
Miss Nicole Elizabeth Dipeppe, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 6518 Meadowridge Rd, Ste 106, Elkridge, MD 21075 Phone: 410-393-0223 |
Henry Tran, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 6682 Huntshire Dr, Elkridge, MD 21075 Phone: 443-520-5184 |
Janet Angelique Browne-avery, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 6095 Marshalee Dr, Ste 100, Elkridge, MD 21075 Phone: 443-871-1876 Fax: 866-515-2777 |
News Archive
Researchers at Harvard Medical School and Columbia University in the United States have developed a way to study the functions of hard-to-grow bacteria that contribute to the composition of the gut microbiome. The new method is published in the journal Molecular Systems Biology.
Biologics, Inc., an oncology management company, has been recognized by the National Comprehensive Cancer Network® (NCCN®) for its commitment to supporting patient access to quality oncology care. For the first time, the NCCN, a not-for-profit alliance of 21 of the world's leading cancer centers, is recognizing commercial payor and non-payor organizations, including Biologics, which support the appropriate, effective, and efficient use of oncology treatment and care of patients through its new NCCN Recognition Program.
Using catheter-based ablation instead of medications alone reduces the risks of death and stroke in patients with the common form of heart arrhythmia known as atrial fibrillation, or AFib, new research from UC Davis physicians shows.
Molecular Detection Inc. (MDI), a company developing Detect-Ready tests designed to increase the speed and accuracy of infectious disease diagnosis, and life sciences and diagnostics distributor Eldan, a part on the Neopharm Group, today announced that they have entered into an exclusive agreement for distribution of MDI's Detect-Ready MRSA Panel in Israel and the Palestinian territories.
› Verified 6 days ago